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Title: 
A qualitative exploration of evidence-based decision-making in public health practice and 
policy: the perceived usefulness of a diabetes economic model for decision-makers. 
 
Key Messages: 
 The diabetes model was perceived as beneficial for decision-making in public health  
 Implementation of the diabetes model to assist evidence-based decision-making was 
perceived as problematic 
 Organisational constraints linked to limited resource, financial constraints and local 
priorities impacted decision making 
 Stakeholder institutional logics were a potential barrier to the use of evidence from 
the economic model in public health  
Abstract: 
 
Purpose: 
The purpose of this paper is to explore the perceived usefulness of a diabetes economic model 
as a potential tool for aiding evidence-based decision-making in public health practice. 
Methods: 
Fifteen semi-structured interviews and two focus groups with four participants each were 
conducted with health and management professionals working in one public health 
department in a local council.  Data were analysed using inductive thematic analysis to 
generate four themes.  
Findings: 
Findings reflect the attitudes and beliefs of a diverse staff group situated in 
public health services.  They demonstrate that the economic model had perceived usefulness, 
and participants reported positive views regarding the principles of economic modelling for 
decision-making.  The model was perceived as useful but potentially problematic in practice 
due to organisational constraints linked to limited organisational resources, restricted budgets 
and local priorities.  Differences in the institutional logics of staff working in public health 
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and stakeholders from local government were identified as a potential barrier to the use of the 
diabetes model in practice.  
Discussion: 
The findings highlight anticipated challenges that individuals tasking with making decisions 
for public health practice and policy could face if they selected to implement an economic 
modelling approach to fulfill the evidence needs of decision-makers.  Previous studies have 
revealed that healthcare decision-makers would find evidence around the economic impacts 
of public health interventions useful, but this information was not always available in the 
context or format required.  This paper provides insights into how staff working in public 
health perceive economic modelling and explores how they consider evidence from a diabetes 
model when making public health practice and policy decisions.   
 
Keywords: 
Decision-making, diabetes, economic model, public health policy, qualitative  
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Research article: 
 
Background:   
Since 2012 local governments in England have been given renewed responsibility for public 
health services as part of the government’s health and social care reforms.  The transition of 
public health from the National Health Service (NHS) to local government was generally 
welcomed (The King’s Fund 2015).  Public health teams work with national and local 
stakeholders to make decisions about local population health policy and practice.  However, 
there is a lack of understanding about what evidence is beneficial in supporting the complex 
and challenging decision-making processes in the context of public health services 
(Rychetnik et al. 2002; Grol and Grimshaw 2003; Pentland et al. 2011; van der Heide et al. 
2016).  A recent systematic review of evidence use in public health decision-making reported 
a need to understand and respond to evidence needs of decision-makers (Kneale et al. 2017).  
The review called for a more collaborative approach to decision-making to improve the 
underutilisation of research evidence South and Cattan (2014) demonstrate the importance of 
using effective knowledge translation processes to encourage evidence-based public health 
policy and practice. Decisions are required about how to prioritise services and select actions 
and interventions that are deemed most effective.   
Information and resources have been developed to help decision-makers answer complex 
questions about 'what works' in improving public health and reducing health inequalities (The 
King’s Fund 2015).  There has been an increasing interest in how to determine ‘value for 
money’, economic ‘return on investment’ (ROI) and the use of effectiveness analyses in 
public health practice (Public Health England 2014).  These types of decisions can be 
informed by economic modelling and a variety of economic tools have been made available 
to decision-makers, e.g., the NICE Physical activity ROI tool (NICE 2017).  
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Evidence from economic models can be a valuable source of information for decision-making 
as modelling provides a framework to evaluate the arguments of the value for money of 
different options (Drummond et al. 2015).  Public Health England encourages the use of ROI 
and cost-effectiveness tools for decision-making at the local level (Public Health England 
2017).  Similarly, the Centres for Disease Control and Prevention, and the World Health 
Organisations promote and provide access to multiple economics tools aimed at public health 
practitioners (CDC 2017; WHO 2017).  However, economic models are not perfect and, in 
some cases, may not be helpful to the individual decision-maker on the ground (Loveman et 
al. 2003; Williams et al. 2008; Weatherly et al. 2009).  Models often have a specific focus and 
may use different data sources or assumptions than what is required or available in public 
health teams (Public Health England 2014).  This has resulted in the intended users not being 
clear about which type of tool and economic evidence is appropriate for their specific context 
(Public Health England 2014). 
Research is limited into the views of those individuals responsible for decision-making 
regarding how useful evidence from economic models could be in real-world public health 
contexts (Eichler et al. 2004; Katikireddiet al. 2014; Haddix et al. 2003).  Previous studies 
have revealed that decision-makers would find evidence around the economic impacts of 
interventions useful, but this information was not always available (Marsh et al. 2013; Marks 
et al. 2015; Hunter et al. 2016; Willmott et al. 2016).   
The purpose of this paper is to explore the perceived usefulness of a diabetes model as a 
potential tool for aiding evidence-based decision-making in public health practice. The study 
sought to discover the factors which influenced the models acceptability across different 
stakeholder groups responsible for public health services for local populations.  
The diabetes prevention model  
This paper explores the usefulness of a diabetes prevention model which aims to assist in the 
evaluation of a broad range of diabetes prevention interventions and spending scenarios 
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across public health services (see appendix A1 for a model summary) (Breeze et al. 2016; 
Breeze et al. 2017a; Breeze et al. 2017b).  This model operates within a spreadsheet where 
local population data can be inputted and different public health interventions selected to 
determine a range of potential outcomes. The model could help to inform decisions regarding 
effective and cost-effective intervention strategies where evidence is strong, and on research 
gaps and priorities for applied public health research where evidence is limited. The perceived 
usefulness and transferability of the diabetes model from the academic setting into public 
health practice is unknown.  Therefore, the study sought to address this gap and contribute to 
the growing literature focused in the domain of evidence-base public health practice (Marks 
et al. 2015; Hunter et al. 2016; Kneale et al. 2017).  It was necessary to determine the 
likelihood that the model could be perceived as potentially useful for individuals responsible 
for making local decisions about public health practice.  
 
Methods: 
Aim and design  
This study aimed to explore the perceived usefulness of a diabetes economic model as a 
potential tool for aiding evidence-based decision-making within the public health department 
of one local government organisation. The study adopted a constructivist framework during 
data collection and analysis as qualitative methods were selected to investigate attitudes, 
beliefs and meanings of staff regarding an economic modeling approach in public health 
decision-making (Pope and Mays 2000).  Twenty three participants were recruited in total, 
through 15 semi-structured interviews and two focus groups containing four participants each. 
Data  were conducted between July 2015 and January 2016.  The purpose of this paper is to 
explore the perceived usefulness of an economic model as a potential tool for aiding 
evidence-based decision-making in public health practice. 
 
The authors considered the economic model as an 'innovation' and therefore drew on current 
conceptual and theoretical frameworks on the diffusion of innovations to inform the 
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investigation. One framework, which informed the study was Normalisation Process Theory 
(NPT) which attempts to identify the issues which affect the adoption and implementation of 
new innovations within organisations (May 2006, May et al. 2009). During the study the 
authors explored the idea of using NPT constructs to map the key findings. 
 
Setting and participants  
The study was conducted within the public health department of one local government in 
England, referred to as ‘Mardestone’.  Mardestone serves a population of approximately 
300,000 people.  Potential interview participants were recruited using a purposive sampling 
technique. The interview participants were identified via the research lead working in the 
public health department. The research lead provided contact details for those individuals 
responsible for public health decision-making. Each contact was emailed the details of the 
study and an invitation to participate. To maxmise the reach of the sample the focus group 
participants were identified through attendance at monthly public health committee meetings. 
Focus groups aimed to include a range of stakeholders from different areas of the council. 
The committee attendees were emailed and invited to participate in a focus group about 
decision-making in public health. All 23 participants were involved in public health decision-
making and originated from various divisions within the local government organisation, 
including public-health practitioners/commissioners (PHS) the finance and contracts teams 
(FC), senior managers/directors in local government (SEN) data and audit analysts (DAT) 
and elected local councillors, cabinet members (EM) (see Table 1).  
 
<Table 1 about here>  
 
Data collection and inductive thematic analysis  
Senior managers in Mardestone approved the conduct of the study in the council building and 
ethical approval was established.  Once consent was obtained the diabetes model was 
described to participants using a short presentation in the focus group or text-based summary 
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during the interview.  Participants were provided with a hypothetical scenario for two 
different public health interventions, and were asked to describe their views on how and if 
they would integrate the evidence from the model into their decision-making practices. A 
topic guide was generated to help guide the interviews questions and focus group discussions. 
A copy is provided in appendix A2.  
 
Data collection was conducted by two study authors (XX and XX). Each interview lasted 
approximately 40 minutes and focus groups 60 minutes. Data were recorded and transcribed 
verbatim professionally and stored in NVivo 12 data management software (QSR 2016). The 
study adopted a broad approach to inductive thematic analysis (Braun and Clarke 2006). 
Interview transcripts were read and a coding framework was developed to structure codes as 
they emerged.  To ensure reliability of the coding the two study authors coded a subset of the 
transcripts independently and met frequently to discuss codes and develop a coding frame. 
The coding frame acted as a thought aid to help structure the new and developing codes as 
they emerged during the data analysis.  
 
Twenty-three preliminary codes were generated and expanded or collapsed into similar 
category groups.  Each theme was generated through an iterative process of refining emerging 
ideas and expanding on developing concepts presented in each of the categories (Mays and 
Pope 1995; Bernard and Ryan 2010).  It was important to return to the study aim during the 
coding and analysis process. Analysis resulted in four themes which formed a complete 
representation of the data set.  To maintain consistency, auditability and credibility, a final 
cross-check of both authors interpretation with the original data and study aim was conducted 
to ensure deviation had not occurred between each theme and its meaning (Sandelowski 
1989; Mays and Pope 1995; Creswell 2009). 
 
Findings:   
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Four themes emerged from data analysis: acceptability of the economic model in public 
health decision-making; a tool in a large decision-making toolkit; the influence of 
organisational context on model usefulness; and the transferability between professional 
contexts and institutional logics.  In this study, NPT enabled creative thinking about the 
implementation processes in the local government setting. The theory enabled the authors to 
make sense of and situate the analytic findings as it helped to structure the way the data was 
coded and analysed.  The final research themes align to the core constructs NPT (See Figure 
1). The constructs help to represent the different kinds of issues that participants described 
when planning to implement the economic model. This process helped to guide the emerging 
interpretations, conclusions and recommendations of the research. 
 
 
< Figure 1 about here> 
 
Figure 1. Visual representation of the four thematic findings 
 
Together four themes reflects the attitudes and beliefs of decision makers regarding the 
usefulness of evidence from the diabetes model. The findings highlight the issues that might 
promote or inhibit the use of the model in practice, and the contingencies that influence how 
effectively the diabetes model could be mobilised from an academic setting where it was 
developed to public health context where it would be used.  
 
Acceptability of the economic model in public health decision-making   
The participants generally held positive attitudes regarding the potential use of the diabetes 
model for evidence-based decision-making in their organisation. Participants considered 
economic modelling to be a credible approach for solving complex decision problems in 
public health. As described in the participant quote below: 
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“This model gives us an intelligent, sensible estimate of what we think will happen, a really good way 
into that decision-making process. I think Mardestone needs to get into a cycle of evidence-based 
decision-making. And tools like this are essential for us to make those decisions and change the culture 
about how we do those kinds of things in the future.” (PHS73) 
 
Data from public health practitioners revealed that they reported to try and integrate research 
evidence into decision-making processes.  It appeared that this was to establish a sense of 
reliability in the decisions, and to counteract the drive from other stakeholders to make 
decisions without an appropriate evidence base. A participant from finance and contracts 
team described this non evidence-based approach to decision making as “finger in air”:  
 
“Anything that can give us just more around that analytical side to actually base commissioning 
decisions, I’d be fully in support of. Everything we try and do is to get an evidence-based approach to 
commissioning (policy planning), I think it would be really useful if it worked, and people would use it 
in the correct way and commit their time and resources to doing it. Any evidence that you put into that 
thinking is always of benefit. So we’re not just going ‘oh a bit of that. There’s a lot of that that goes on, 
finger in the air sometimes. I think that’s not a healthy approach to things.” (FC74) 
 
Generally, the findings indicate that the diabetes model could generate formal pieces of 
evidence which participants believed was beneficial to decision-making. An elected member 
of the council felt that economic evidence could potentially improve accountability and 
credibility of public health decisions:  
 
“It gives it more credibility, to actually spread it out and get other people using it and buying into it.” 
(EM83) 
 
Participants described how the evidence generated from the model could provide an 
opportunity to “spearhead culture change” in public health practice, such as planning new 
strategies (SEN82).  However, other participants suggest that these beliefs appeared to be 
grounded on intuition rather than previous experience of implementing and using similar 
models to achieve strategic change. As described by the data analysis below:  
 
“I think my gut feeling is that it would work if it was embedded in a broader commissioning or 
planning strategy or approach. If it was treated on its own or taken on its own, I think it probably be 
seen as sort of geekish and a bit techy.” (DAT69) 
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The diabetes model appeared to naturally lend itself to the work of public health decision-
makers, as it offered evidence on different public health scenarios and cost returns for a 
diverse range of policies. A public health practitioner described this as evidence used in 
“decisions on where to put the books”. The evidence generated by the model potentially 
helped participants  tangibly compare the distinct scenarios that were available to them during 
decision-making.  
 
“As a commissioner any tools that we can use that helps me make decisions on where to put the books 
is probably a really good thing, it's a good starting point to understand what impacts they have and 
what, how much in terms of long term or short term savings and then decisions can be made on which 
way we go.” (PHS81) 
 
However, these positive beliefs about potential usefulness might not necessarily translate into 
an intention to implement the diabetes model in practice.  There were various explanations for 
why implementation might not be realised linked to local awareness, accessibility and 
understanding of the model and the prioritisation of diabetes prevention as a disease area 
within the organisation.  These factors appear to restrict the chance that the model would be 
implemented and used practice.  The quote below from a data analysis describes how the 
diabetes model might not align to the current health prevention schemes and priorities within 
Mardestone local government:  
 
“It is (useful). But there's a step before that though, in which we actually identify the local priorities 
for Mardestone which we should channel the financial resources and human resources, and if we 
identify that Mardestone had a particular problem with diabetes then it probably wouldn't be a 
problem at all getting ‘by in’ into this tool. But if other conditions were being seen as more 
problematic… to secure funding and time, limited funds limited time to something where we seem to be 
mid table rather than in the relegation zone.” (DAT68) 
 
The findings indicate concerns as to whether the model developed specifically for diabetes 
prevention could align to current or planned local priorities at Mardestone.  An independent 
academic team designed and created the model, and its focus on diabetes appeared to be an 
obstacle for the participants, as echoed in the following quote from a public health 
practitioner:  
 11 
 
“I think if we’d have commissioned the tool ourselves, we probably wouldn’t have said focus down on 
diabetes. For us, reducing obesity affects long-term conditions.” (PHS72) 
 
Differences were found in the ways in which national and local issues were framed during 
public health decision-making at Mardestone.  The inconsistency in views regarding the 
priority of diabetes in particular was an unexpected finding.  Diabetes prevention is national 
priority in the UK and is a current focus of Public Health England (NHS England 2016).  A 
programme of diabetes work spanned many areas of the public health department at 
Mardestone, including staff responsible for obesity, physical activity and health education.  
The differences demonstrate a tension in priority setting for either local or national population 
health and the distinction between the medical and social model of health.  The former tends 
to support a disease specific focus, whereas the latter takes a more holistic view on the wider 
determinants of health and wellbeing, more typical in local government.  In the findings, the 
specific disease focused model was called into question more so than the usefulness of 
economic modelling as a tool to support decision-making.  
 
A tool in the large decision-making toolkit  
A common theme in the data was reference to the diabetes economic model as another tool 
that could be added to existing decision-making processes within Mardestone.  Therefore, the 
evidence from the model was perceived as another useful another source of evidence in the 
mixed economy of knowledge in public health:  
 
“It’s one of the tools in the tool-box for decision making.” (PHS73) 
 
Evidence generated from the model was considered supplementary to existing decision-
making practices rather than something that could replace what had gone before. Data suggest 
that the model would help facilitate better quality decisions compared to other options 
available. The model evidence could be integrated and used alongside other approaches 
 12 
during public health decision-making.  The discussions focused on how participants could 
appropriately combine different approaches and types of evidence together to encourage 
evidence-based decision-making.  This finance and contract participant describes decision-
making in Mardestone as a “whole combination of that kind of stuff”: 
 
“Most of the stuff I’ve worked on, they’ve shown what they’ve done evidence wise, yes consultation 
exercises, and data. It’s a whole combination of that kind of stuff.” (FC74) 
 
In isolation, the diabetes model was considered limited in its usefulness, this appeared to be 
due to suspicion regarding the perceived “black box” nature of economic modelling methods 
(SEN67).  Despite reservations, there was awareness among participants of the need to 
conduct more formal and structured decision-making process in Mardestone.  Economic 
modelling was viewed as an appropriate approach which could help to generate the ‘hard’ 
evidence required for public health decisions.  The need to consider investment in public 
health rather than cost effectiveness of interventions is relatively new in this environment and 
could be a product of austerity.  The public health practitioner below describes the necessity 
to determine a “return” on investment within public health practice at Mardestone: 
 
“So we need to provide a case for the services we’ve commissioned.  We need to monitor the effects of 
our interventions so that we can look at the monetary value of what we are doing.  We are not just 
spending money, this is a return.” (PHS72) 
 
The findings revealed that the usefulness of the model could be facilitated through promotion 
of it as part of the decision-making toolkit. In this sense, the diabetes model could provide 
decision-makers with an additional source of evidence for consideration.  Evidence from the 
model would need to be explained to decision-makers and compared alongside other 
considerations. Public health policy and practice decisions in Mardestone required mixed 
knowledge from a variety of stakeholders, including those with experience in other areas of 
local government decision-making such as social care services. It maybe necessary for public 
health practitioners to ensure that evidence created an economic modelling approach was 
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appropriate in the local context and aligns to the processes of decision-making in their 
environment.  
 
The influence of organisational context on model usefulness 
Participants reported a range of organisational factors which potentially limit the usefulness 
of the diabetes model in practice.  Particular difficulties related to the perceived 
implementation problems on the ground, and the ‘fit’ of the model to local context, skills and 
resources. The problems identified are not new and have been reported elsewhere, however 
they provide an important understanding the context of local government. There was a 
presumed lack of flexibility and appropriateness of the model in the context of public health 
decisions.  Participants described prominent barriers linked to financial constraints, economic 
pressures and resource challenges.  Practical considerations included the potential availability 
and capability of local staff to use the model to its full potential, and their technical capacity 
and expertise to operationalise the model and interpret the outputs. One data analyst reported 
“lacking sophistication” and modelling “capacity” in their department which suggests a 
‘front end’ interface would be required to make the evidence usable in practice:  
  
“We just lack the sophistication to be able to do it. Very few places would have the capacity to be able 
to take the time to do that kind of work. I don't think we do it now because we haven't got the capacity, 
we haven't got the time, and we haven't really got the skills, there aren't sophisticated modelers. 
Modelling tools will play an increasingly important part in what we do, but the ability of us, having a 
team big enough to create those models is decreasing.” (DAT69) 
 
Other participants perceived their lack of skill meant they would not be able to confidently 
mobilise the results and evidence from the model into practice.  This public health 
practitioner described not being “qualified” in a “mathematical discipline”: 
 
“I’m not qualified to say how good the tool is and what it does, you would have to take advice from 
somebody who understood how the modelling was done which I assume is the mathematical discipline, 
which I’m not.” (PHS80) 
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To overcome this challenge it would be important to tackle some issues regarding decision-
making using an economic modelling approach that were identified in the study.  One 
reported problem was the localisation of the model to support evidence-based decision-
making processes in local government.  Participants described the need to have an 
organisationally specific model to ensure its success in context, for example lifecycle data and 
outputs from their projects should be incorporated into the model before it would be 
perceived as useful in practice:  
 
“My main involvement has been to try and Mardestone-erise it (the model). When we were presented 
with the tool we were presented with a set of data that were based on generic or national populations. 
We felt the first thing that was quite important if you were going to get it to be useful, you had to make 
it Mardestone specific.” (DAT69) 
 
Participants reported the need to be able to justify adopting a modelling approach to senior 
decision-makers.  This staff member states that it would be essential to “convince our 
governing body and senior management” that the model would be a positive investment in 
Mardestone:   
 
“The key challenge would be convincing the governing body to do this rather than do something else. 
We've got limited funds, if there was a financial impact we'd have to justify spending it on this tool. 
Would there be any financial implications, would it cost us anything, how much staff time? It would be 
convincing our governing body and senior management team that any financial or time that was 
required to be spent on this model was worthwhile.”(DAT68) 
 
The findings revealed a strong influence of a hierarchical structure within the public health 
department and wider local government in Mardestone.  This organisational norm impacted 
on the decision-making process and centered decisions around the opinions of individuals, not 
what was presented in the evidence. As represented in the quote below:  
 
“Local authorities are very much more hierarchal, we have an electoral system. We would write a 
report, it would be based on evidence, you'd have done everything right, and normally everything 
would be based on that. Here it can change because of an individual’s view. And that's the system that 
we work in. Decisions made have to go through a process, we have to present the information and then 
decisions are made.” (PHS81) 
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A variety of organisational constraints were reported as impeding the potential usefulness of 
the model in practice, for example budget cuts within local government and balancing 
priorities across the organisation.  Concerns were raised regarding the ‘fit’ of the model in 
context because it did not align to the organisational view of timeliness.  The findings 
demonstrated a desire to achieve instant results from decisions as opposed to planning longer-
term time horizons for outcomes of investments. The participant below suggested that 
stakeholders would not be prepared to wait for the outcome of policies that the diabetes 
models suggested were the most appropriate:  
  
“Sometimes people demand results. I can understand where they are coming from but some things 
don’t get results really quickly. Part of that is a bit of culture change in terms of what people can 
expect.” (PHS73) 
 
Participants working in Mardestone revealed they had little control and authority over many 
organisational decisions due to the significant budget cuts within public health and the wider 
local government.  This restriction limited what decisions they could action “even though it 
might be the right thing to do”. As described in both examples below:  
 
“Yeah and budget constraints.  You know if it’s too expensive it might not happen, even though it might 
be the right thing to do.” (PHS73) 
 
“I think the biggest issue we’re going to have is more cuts. So we’ll see how it goes after next year’s 
budget.” (EM83) 
 
There was an understanding that evidence-based decisions which potentially save money, 
might still be the ‘wrong’ decision in the context of broader organisational politics. The 
public health practitioner below refers to this as the “political agenda”:  
 
“That comes back to funding and what the political agenda is at that time, it constantly changes. 
Everything can’t be a priority obviously, but then they are looking at the figures that you really plough 
money in and plough resource in that obviously comes down as a problem, but then you’ve got 
something else in the meantime so you’re constantly trying to balance them.” (PHS80) 
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This represents a separation between decision-making that privileges evidence from evidence-
based sources, such the diabetes model and those which focus on the political agendas of an 
organisation and opinion leaders.  In public health policy and practice, the usefulness of an 
economic model as an evidence generating mechanism must be considered in the context of 
all these locally contingent factors.  Assuming the model would be fit for purpose at one 
level, for example by providing training to an individual data analyst, may not be sufficient to 
ensure that the output and evidence generated from the model will be influential and 
acceptable in decisions made across the broader organisation.   
 
Transferability between professional contexts and institutional logics 
The competing norms and institutional logics that were present in the public health services at 
Mardestone local government reflect the wide range of stakeholders who are responsible for 
making decisions about public health policy and practice.  In this study, the differing 
institutional logics appeared to impact the perceived usefulness of the diabetes model for 
facilitating evidence-based decision-making.  Public health practitioners, who originated from 
a healthcare environment, tended to subscribe to the norms of clinical science which 
underpins evidence-based medicine.  Other participants working across the wider remit of the 
local government, such as social care or management sector did not subscribe to the logic of 
clinical science in the same way (Dunn and Jones 2010).  The perspectives and logics of 
different individuals did not always align and therefore complicated decision-making 
processes.  This participant from finance and contract describes the different approaches to 
decision-making between staff at Mardestone:  
 
“Public health, what they bring is a kind of education scholarly approach to things, and that’s 
different. That’s very much evidence-related and population, because that’s the nature of public health. 
Whereas social care sometimes are not so evidence-based-led. It’s a bit ‘well I thought that’ more fly 
by the seat of your pants in social care.” (FC75) 
 
This quote illustrates the way in which decisions makers tended to stereotype individuals into 
different groups relative to their professional background, for example stating that public 
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health practitioners are “very much evidence-related”. Despite these beliefs the differences 
were not clear cut. All decision-making included those in public health department required a 
mixed economy of knowledge to make decisions within the local government context as 
described below: 
 
“We would look at all the evidence, look at all the data, look at best practice elsewhere, and then we 
would go and consult with the community in some way.” (PHS81) 
 
The findings revealed that participants not subscribed to a science logic consequently did not 
privilege evidence-based medicine in the same way as public health practitioners.  The 
perceived value of the evidence generated from the diabetes model was limited because it 
aligned to the traditions of evidence-based medicine.  The diverse views from the range of 
participants across the organisation could not seamlessly integrate into the day-to-day 
decision-making practice of the public health department, as described below by the public 
health practitioner:  
 
“I am not sure evidence is valued in the same way in the local authority even though I think it is in 
public health. For example I might consult with ten people in the community and they say this 
intervention is a really good idea. They might put more sway on those ten people than something that’s 
had loads and loads of work gone into it and is really objective.” (PHS72) 
 
One public health practitioner illustrates how an evidence-based approach would normally be 
followed as an “automatic go to” in public health decision-making processes prior to public 
consultation (PHS81).  
 
The findings question the acceptability and appropriateness of evidence from an economic 
model grounded in traditional evidence-based medicine and the logic of clinical science for 
use public health decision-making. In local government and public health services, evidence 
is required for decision-making but the diverse views of stakeholders meant that definitions of 
evidence were not concrete or agreed upon.  Evidence could constitute output from the 
diabetes model or the experience of an individual member of the organisation. Participants 
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reported that different types of evidence would be used in combination, and the point at which 
each type became important varied amongst participants depending on their prevailing 
institutional logic. The data analyst described how decisions may change depending on the 
individuals involved:   
 
“You start with the best evidences available and you build up what you're going to do based on that, 
talk to the various experts around the room. Once you've done that you've got to go to the elected 
members, and say this is what we want to do and they will possibly say 'well yeah that's all very well 
but what's it going to do for (our local) community’. We don't tend to start with the evidence, build it 
up. So I suppose it's a very indirect way of saying, this kind of evidence base which is part of an 
evidence base, is kind of muddled.” (DAT69) 
 
The way in which the different types of evidence were bought together during public health 
decision-making was flexible.  Decisions sat firmly in the domain of contextual practice 
where the focus was on the local circumstances and the ‘fit’ of decisions for the local 
population of Mardestone.  Therefore, evidence from the diabetes model was perceived as 
useful and appropriate if it could fit within the current context in which decision-making 
occurs.  However, a changing decision context could potentially impact the usefulness of the 
model in the future. 
 
Discussion: 
Decision-making for the selection of public health interventions and local population services 
has been described as complex and challenging process (Rychetnik et al. 2002; Grol and 
Grimshaw 2003; Pentland et al. 2011; van der Heide et al. 2016).  This study sought to 
explore the perceived usefulness of evidence from an economic model for type 2 diabetes, as 
a potential tool for aiding evidence-based decision-making in public health practice.  Public 
health services located within local government in England provided a novel opportunity to 
investigate the types of evidence and approaches to decision-making prominent in this 
environment.  Findings revealed four themes which reflect perceptions about the usefulness 
of an economic modelling approach and the diabetes model from a diverse group of 
participants.  The challenges identified would promote or inhibit the use of the model were 
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described, along with the contingencies of practice that might influence how effectively the 
model could be mobilised from the academic domain where it was developed into the public 
health department where it would be used to inform policy and practice decisions.  
 
Generally positive views were identified regarding the potential contribution of evidence 
from the diabetes model to public health decision-making. Modelling is an approach that 
could provide the ‘hard’ evidence to justify decisions in this complex environment where 
many competing positions and ever-declining budgets exist.  Factors which could potentially 
hinder the implementation and use of the model in practice included; availability of staff with 
suitable knowledge and experience of modelling, staff with technical skills to ensure effective 
use of the model coupled with the ability to confidently promote the output to senior decision-
makers at Mardestone. The hierarchical structures of Mardestones decision-making processes 
and the existing service priorities and provisions across the local council were also 
problematic. The themes identified in this study have been documented in a variety of settings 
(Gkeredakis et al. 2011, Powell et al. 2017), although not focus on public health in local 
government settings. Walter and colleagues described the importance of the interactions 
between researchers and research users, and the need to provide a supportive context to 
encourage research-based practice (Walter et al. 2005).  
 
The focus of the model on diabetes did not always align to the service priorities within the 
council as participants described the need to focus attention on obesity in their service. This 
demonstrates the importance of developing an economic model in partnership with council 
who are responsible for making local decisions. Organisational resources, in particular the 
financial and budget restraints were also a limiting factor in whether the model could be 
considered appropriate. Financial issues restricted the potential decision options regarding 
interventions which may not be viable in the future, and made managers of the local 
government cautious of committing staff time to analytical work not seen as a priority.  This 
finding supports previous research which found that organisational factors impacted on the 
 20 
success of interventions aimed at increasing research use in public health policy decision 
making (Zardo et al. 2015) 
 
The transition of public health to local government in England, has interrupted the flow of 
research evidence into practice and heightened the political element to decision-making, 
allowing it to be more visible and localised (Kneale et al. 2017).  This raises debate regarding 
the boundaries between public health and politicians, where the former appear to argue for a 
superior evidence-based method compared to the diverse sources of evidence privileged by 
other stakeholders.  Contrary opinions on the best course of action reflect the differing 
objectives and priorities of individuals working in public health and demonstrate the 
challenge of integrating economic models grounded in evidence-based decision-making.  It is 
possible that the boundary between decision-making norms and processes could be bridged to 
facilitate collaborative decision-making, economic models and the evidence they produce 
could be a fruitful area to pursue. However, the negative perceptions about the model 
identified in this study would need to be tackled first, for example the belief that it was not or 
could not be tailored to local circumstances and priorities.  Increasing awareness of the aims 
and methods of economic modelling across all stakeholder responsible for public health 
decisions might help address these challenges as some views were supported by instinct as 
opposed to experience of using the model and its output. 
 
Participants reported potential problems in using the model in practice because it might not 
align and support the preferred approach to decision-making at Mardestone, where local 
views and political agendas were prioritised over other forms of evidence.  This appeared to 
be a consequence of the legacy decision-making norms within the organisation and differing 
institutional logics of individuals working there. According to Scott et al (2000), institutional 
environments may influence organisations through the ‘archetypes they develop for actors, 
the logics they legitimate, and the governance systems and rules they support’.  This study 
found competing views between public health practitioners and other public health decision 
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makers (e.g., finance and contracts) regarding how decision-making does or should take place 
in public health policy and practice, and whether evidence from the model could ‘fit’ into the 
current approach.  Disparities reflect the implicit and socially shared rules that existed for the 
participants regarding what acted as legitimate sources of evidence for them in their decision-
making, and their differing objectives and priorities for local government policy (Greenwood 
et al. 2002).  Evidence sources included clinical evidence and national population data, and 
the views of small groups in the local community or output of larger consultation exercises.  
The perceived usefulness of the model outputs as a source of evidence was inhibited because 
it did not align with the dominant logic of decision-makers within Mardestone (exemplified in 
respondents’ narratives within the social care teams).  
 
A central finding was the importance attached to the local context in public health decision-
making at Mardestone. Public health decisions made in this complex setting required health 
and social care priorities to be considered, but they were not linear or straightforward, and 
therefore tended not to be made using crude parameters of success. This echoes a recent study 
by Fitzgerald and colleagues (2017), which demonstrate that  public health data and statistics 
were not valued or understood by individuals responsible for generating public health policy.  
In this participants study required multiple sources of evidence during decision-making, 
including evidence from academic and traditional evidence-based sources, local populations 
and individual experiences.  The outputs of the diabetes model were another source of 
evidence to be added to this mixed economy of knowledge in public health decision-making.  
The findings support recent research which promotes the combination of multiple types of 
evidence in public health policymaking (Cairney and Oliver 2017).  Decision makers must 
recognise that traditional evidence-based approaches may not always be appropriate in the 
context of public health and local government, and therefore approaches such as economic 
models might not transfer from one context to another.   
 
Implications for research and practice 
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Public health policy and practice decision-making consists of various ‘wicked problems’ as 
those tasked with making decision are faced with long time horizons, complex systems of 
causation and unclear responsibilities spread across multiple stakeholders.  This study sought 
to discover whether and how evidence from the diabetes model might fit into the decision-
making toolkit used in public health.  What became clear was that there was no ‘right’ way in 
which the differing ideals regarding the process and practice of decision-making were 
negotiated.  Evidence from the economic model was a perceived as a valid source of evidence 
for public health decision-making, however it did not substitute evidence from other decision-
making tools and approaches.  Instead, the model was perceived useful in the promotion of 
more structured decision-making processes within the current unstructured, complex and 
changeable environment.   
 
It is important to recognise the need to improve the health of the public by engaging in a 
much wider spectrum of planners and decision-makers. This requires going beyond those who 
typically label themselves as public health practitioners and therefore have perceived 
responsibility over decisions.  The findings highlight the highly politicised nature of 
commissioning within local authorities and contribute to the growing literature of 
implementation science. The study emphasises the dichotomy between functionalist, practical 
and materialist explanations that have dominated previous implementation science research, 
compared to the focus here on the more subliminal, latent and hidden dynamics and agendas 
driving action. This is not to deny that the explicit measurable drivers are important, but to 
argue that the implicit and less measurable ones are important too.   
 
In this study, the majority of public health practitioners were previously been located within 
healthcare where economic modelling and evidence-based medicine were customary.  
Participants from outside of health held differing views, and their dominant evidence source 
changed depending on local priorities of Mardestone.  This inherent flexibility limited the 
potential usefulness of the diabetes model, as it was not automatically valued as applicable to 
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all the needs of decision makers.  A key message is the need for transparent decision 
processes, so that individuals with differing ideals are able to communicate and share views 
about what they consider to be important evidence for decisions and why it should be 
considered over other options.  Individuals working in public health within local government 
may choose evidence from economic models to help guide planning and investment 
decisions, but they need to be communicated and discussed with all those responsible for 
decision-making. To extend the findings of this study, an investigation into the 
implementation of the diabetes model and impact that is has of decision making is required. 
This is an area for future research, which may help to ensure that decisions made for 
populations are based on considerations of the best available evidence.  
 
Strengths and limitations  
This investigation is one of the first to examine the perceived usefulness of a diabetes 
economic model specifically in the wider public health local government setting. The findings 
presented and discussed demonstrate the increasing need to understand the factors that 
influence acceptability of economic models in real-world contexts. The study provides a 
useful insight to researches and practitioners who aim to promote the use of this type of 
evidence in their work. A limitation is that the study included participants responsible for 
public health decision-making within one organisation (Mardestone).  The authors recognise 
that participants were describing decision-making for public health and that local 
governments have wide ranging responsibilities outside of health.  The findings may be 
contingent on this restricted view and could be improved by sampling further into the 
organisational infrastructure.   
 
It was essential to provide significant depth of investigation (rather than breadth) but the 
single case generates questions regarding generalisability of findings. Findings may not  
feasibly be compared elsewhere, due to the diversity in terms of political orientation, 
organisation and skills of public health teams and local public health issues being tackled at 
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Mardestone.  However, understanding generated through this study of evidence-base 
decision-making using evidence from the diabetes model has strong internal validity, 
therefore it has wider generalisability at a higher conceptual level.  This paper has discussed 
whether evidence from an economic model  can ever be appropriate for public health practice, 
where multiple stakeholders spanning larger disciplinary boundaries are responsible for 
decision-making regarding the health of the population.  The study aimed to provide 
significant contextual detail of the decision-making processes so that others could identify 
with their approach to practice.  Therefore, encouraging the uptake of evidence-based 
approaches to decision-making for those working in public health.  
 
Conclusion: 
The diabetes model had perceived usefulness and participants reported positive beliefs 
regarding the principles of economic modelling for decision-making in public health.  
However, the potential implementation of the economic model to assist evidence-based 
decision-making in practice was perceived as potentially problematic, due to organisational 
constraints linked to limited resource, finance and local priorities.  Differences in the 
institutional logics of individuals working in public health in the local government context 
was identified as a potential barrier to the use of the model in practice. 
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Supplementary appendix  
 
A1. A brief summary of the model 
 
Return on Investment Modelling 
Mardestone Weight Prevention and Management: Draft Report for hypothetical analysis 
Introduction 
The prevalence of overweight and obesity across Mardestone is considerably higher than the 
England average.  Mardestone Council is providing a range of evidence based interventions 
driven by local need and incorporating best practice in order to halt the rise in obesity. Tier 1 
and Tier 2 weight prevention and management services have recently been commissioned.  
This exploratory study aims to evaluate the return on investment of a selection of services 
recently commissioned based on their contracted cost and targeted weight outcomes. The 
analysis will provide estimates of the long term benefits of these policies conditional on 
alternative targets to inform ongoing evaluation of services and future re-commissioning. 
Method 
The Model 
The model was developed to forecast long-term health and health care costs under alternative 
scenarios for diabetes prevention intervention. The evolution of individual-level trajectories, 
rather than aggregate characteristics of a cohort are simulated through a micro-simulation 
framework. The model was designed to simulate a representative sample of the UK 
population. For each person, their weight, cholesterol levels, systolic blood pressure and 
HbA1c (a measure of diabetes) fluctuate from year to year, representing natural changes as 
people age. Individuals can develop diabetes, cardiovascular disease (e.g. heart disease or 
stroke), diabetes-related complications, cancer, depression or osteoarthritis over the course of 
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their lifetime. Each disease results in a particular cost to society and a reduction in quality of 
life for the individual. The model was developed in freely available statistics software, R, 
which allowed fast and flexible simulation of patient outcomes.  
The Population 
The baseline characteristics of individuals in the model were generated to be representative of 
the Mardestone Adult population. The Health Survey for England 2011 dataset was use to 
describe individual characteristics needed in the model and to ensure that correlation between 
characteristics (e.g. smoking and systolic blood pressure were maintained). A stratified 
sampling algorithm was developed to select individuals from the Health Survey for England 
to be more representative of the Mardestone population.  
The baseline characteristics of individuals are described in Table 1. 
Table 1: Characteristics of final sample from HSE 2011 (N=8038) 
 Number  Percentage  
Male 3506 43.6%  
White 7212 89.7%  
Indian 188 2.3%  
Pakistani 126 1.6%  
Bangladeshi 41 0.5%  
Other Asian 90 1.1%  
Caribbean 71 0.9%  
African 115 1.4%  
Chinese 35 0.4%  
Other 160 2.0%  
IMD 1 (least deprived) 1700 21.1%  
IMD 2  1699 21.1%  
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IMD 3 1696 21.1%  
IMD 4 1479 18.4%  
IMD 5 (most deprived) 1464 18.2%  
Non-smoker 4310 53.6%  
Past smoker 2105 26.2%  
Light smoker (<10 per 
day) 
589 7.3%  
Moderate smoker (10-
20 per day) 
683 8.5%  
Heavy smoker (>20 
per day) 
342 4.3%  
Anti-hypertensive 
treatment 
2092 26.0%  
Statins 665 8.3%  
Stable angina 135 1.7%  
Unstable angina 42 0.5%  
MI 78 1.0%  
Stroke 179 2.2%  
 Mean Standard deviation Median  
Age 48.59 18.49 47.00 
BMI 27.13 5.18 26.40 
Total Cholesterol 5.42 1.07 5.40 
HDL Cholesterol 1.53 0.44 1.50 
HbA1c 5.61 0.47 5.60 
Systolic Blood 
Pressure 
125.90 16.92 123.50 
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EQ-5D (TTO) 0.836 0.232 0.883 
BMI Body Mass 
Index; IMD  Index of 
Multiple Deprivation; 
EQ-5D 5 dimensions 
Euroqol (health related 
quality of life index) 
   
 
The Interventions 
The hypothetical analysis considered a weight prevention and weight management 
intervention.  
Weight Management 
The intervention was assumed to recruit 500 individuals in the population at random with a 
BMI>30. Individuals attended an educational session on weight loss. In the first year the 
individuals experienced a reduction in BMI of 1kg/m2.  The benefits of the intervention were 
assumed to reduce linearly over a five year period. The intervention was assumed to cost 
£200 per individual in the first year. 
(In final analysis will produce summary statistics of baseline characteristics for individuals 
meeting the intervention criteria) 
Weight Prevention 
The intervention was assumed to promote a low fat diet through poster campaigns in the 
workplace. The posters were assumed to be seen by 5,000 individuals in employment selected 
at random.  In the first year the individuals who saw the posters experienced a reduction in 
BMI of 0.05kg/m2.  The benefits of the intervention were assumed to reduce linearly over a 
five year period. The intervention was assumed to cost £2000 in poster development, printing 
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and distribution costs. 
(In final analysis will produce summary statistics of baseline characteristics for individuals 
meeting the intervention criteria) 
The Outcomes 
The model estimates a number of short and long term outcomes to describe the long term 
benefits of an intervention and to allow comparisons across policies. An interactive excel 
spreadsheet has been developed to enable flexible generation of evidence. Each outcome can 
be viewed at different timescales in years. The analysis also allows the user to view outcomes 
assuming the intervention meets the target for effectiveness, exceeds, or falls short of the 
expected outcomes.  
The SPHR model generates a number of cost outcomes including net cost total NHS cost 
savings and net cost savings (Intervention cost minus NHS cost savings). The NHS costs can 
be broken down by costs attributed to cardiovascular disease, diabetes management and 
cancer.  
Health outcomes include life years, Quality Adjusted Life Years, cardiovascular disease, and 
Diabetes diagnoses. 
The model also estimates the net monetary benefit of the interventions, assuming a 
willingness to pay threshold of £20,000 per QALY. This allows each intervention to be 
compared against a single measure of overall cost and health benefits. All costs and QALYs 
are discounted at 1.5% in line with national guidelines.  
Results 
First, the model evaluates the long term cost in a scenario ‘do nothing’ scenario in which no 
individual health trajectories are altered. The model also evaluates the same individuals health 
trajectories under a weight prevention and weight management scenario in which the health 
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trajectories of a sub-group of individuals are modified.  
Costs 
The cost differences between each intervention and the ‘do nothing’ scenario are described 
below. 
Table 2: A comparison of costs for a population (N=70000) in which some individuals 
are affected by two policies 
 
Weight 
Manageme
nt 
Weight 
Prevention 
    
 1 year 5 year 10 years 1 year 5 year 10 years 
Intervention 
Coverage 
0.7% 0.7% 0.7% 7% 7% 7% 
Intervention 
Cost 
 £100,000     £2,000    
Diabetes 
Cost 
 £0  -£545  -£5,350   £0  -£165  -£2,091  
Cardiovascu
lar Cost 
-£229  -£7,397  -£18,399  -£73  -£350  -£567  
Cancer Cost -£1,225  -£1,935  -£1,935   £732   £732   £732  
NHS Cost -£1,894  -£26,582  -£57,115   £378  -£6,455  -£15,477  
Net Cost  £97,771   £76,288   £49,252  -£1,621  -£4,456  -£13,478  
 
In the first 1 year of follow-up the weight management interventions costs £100,000 to 
implement, and enrols 0.7% of the population. In the following 10 years the NHS is expected 
to accrue over £50,000 of savings. However, over 50 years the savings do not exceed the cost 
of the intervention. In the first 1 year of follow-up the weight prevention interventions costs 
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£2,000 to implement, and enrols 7% of the population. In the following 10 years the NHS is 
expected to accrue over £15,000 of savings. After only 1 year the savings to the NHS exceed 
the cost of the intervention.  
Health gains 
The differences in health between the ‘do nothing’ scenario and the two intervention options 
are summarised in Table 3. 
Table 3: A comparison of health for a population (N=70000) in which some individuals 
are affected by two policies 
 
Weight 
Manageme
nt 
Weight 
Prevention 
    
 1 year 5 year 10 years 1 year 5 year 10 years 
Intervention 
Coverage 
0.7% 0.7% 0.7% 7% 7% 7% 
Diabetes 
Diagnosis 
0.00 -1.12 -2.45 0.00 -0.28 -1.26 
Cardiovascu
lar disease 
-0.07 -0.84 -1.54 -0.14 -0.28 -0.28 
Life Years 0.00 0.28 1.82 0.00 0.28 0.77 
QALYs 0.10 1.21 3.74 0.06 0.48 1.12 
 
Over 10 years the weight management intervention prevents more than two diabetes 
diagnoses and more than 1 incidence of cardiovascular disease. Approximately two life years 
are gained and almost four QALYs.  
Over 10 years the weight prevention intervention prevents fewer poor health events than the 
 41 
weight management campaign. The rate of diabetes diagnoses and cardiovascular disease 
incidence are marginally reduced. Approximately 1 life year and 1 QALY are gained across 
the population and 10 year time horizon for this population. 
Net Benefit 
The total Net Benefit of the interventions valued at £20,000 per QALY is summarised in 
Table 4. This analysis illustrates that the weight management intervention is not good value 
for money until after approximately 10 years. Whereas the weight prevention intervention is 
good value for money from year 1 onwards. 
Table 4: A comparison of net benefit for a population (N=70000) in which some 
individuals are affected by two policies 
 
Weight 
Manageme
nt 
Weight 
Prevention 
    
 1 year 5 year 10 years 1 year 5 year 10 years 
Intervention 
Coverage 
0.7% 0.7% 0.7% 7.0% 7.0% 7.0% 
Incremental 
Cost-
Effectivenes
s Ratio 
 £966,915   £62,795   £13,168  
 Cost 
Saving  
 Cost 
Saving  
 Cost 
Saving  
Net Benefit -£ 95,749  -£ 51,991   £ 25,554   £ 2,746   £ 14,102   £ 35,845  
 
A2. A copy of the interview topic guide  
Topic Guide 
 
Adoption and implementation of a diabetes prevention model to inform local government 
commissioning 
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Context of decision making for public health 
What is your understanding of who makes the health and well being prioritisation decisions in 
Mardestone? 
 What is the role of the cabinet? 
 What is the role of the council? 
 What is the role of other partnerships/CCGs? 
 What is the role of the HWBB? 
 Role of HWBB in priority setting 
 Influence of public health v other professional groups 
 
What are the key public health priorities identified for Mardestone? 
 How were priorities decided on? 
 Have these priorities been identified as part of a strategy? 
 How have the Marmot recommendations by addressed by Mardestone? 
 What are the key strategies in place? 
 Have action plans been agreed on how the priorities should be reached? 
 How does type 2 diabetes compare to other health/public health needs/problems? 
 How does type 2 diabetes affect the local population? 
 
What evidence is required to help commissioning decisions/resource allocation in relation to 
type 2 diabetes? 
 Are they influenced by evidence? Explain. 
 How could commissioning be improved/changed? 
 
Attitudes towards innovation in Mardestone 
 
• What tools are currently used for PH decision making? 
• What is the level of understanding around priority setting held by key stakeholders? 
• Beyond the overarching priorities which areas present a challenge in relation to 
resource allocation, or making difficult trade offs? 
• How have decision tools/models helped/hindered the process? 
 
In your view which tools are useful for prioritising PH investment and why? 
 
 How could the ROI tool be used to inform priority setting around type 2 diabetes 
services? 
 What type of evidence could such a model provide to enhance decision  making? eg. 
Longitudinal, forecast health burden (predictors?), population needs etc? 
 
How acceptable would such a model be in Mardestone? 
 Could it be used by staff/why/how? 
 Could it have broader utility? 
 Who could use it? 
 Is the organisation/culture receptive to innovation? 
 How could the tool be used in routine commissioning decisions/work at Mardestone? 
 
Specific enablers and barriers to adoption of the tool/new innovations 
 
 The ROI modelling tool? 
 How could any barriers be overcome? 
 Who is most likely to adopt the tool? 
 Does it make sense  (coherence) to use the tool in the way it was designed? Why? 
How? 
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 Will other employees adopt the tool? 
 How  much visibility has the tool received in Mardestone Council? What is the effect 
of tool visibility/invisibility? Eg collective (in) action. 
 Could the tool be extended beyond diabetes? Explain. 
 
